Table 2.
Characteristics at start and end of each treatment arm for 16 preobese subjects
| Characteristic | HD arm | P | LD arm | P | PL arm | P | |||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||||
| Start M ± SD (95% CI) |
End M ± SD (95% CI) |
Start M ± SD (95% CI) |
End M ± SD (95% CI) |
Start M ± SD (95% CI) |
End M ± SD (95% CI) |
||||
| Weight (kg) | 72.86 ± 8.91 (68.11–77.61) | 70.82 ± 8.40 (66.34–75.30) | 0.002 | 71.25 ± 7.30 (67.36–75.14) | 69.71 ± 7.30 (65.82–73.60) | 0.003 | 72.15 ± 8.64 (67.55–76.75) | 72.47 ± 8.47 (67.96–76.98) | 0.353 |
| BMI (kg/m2) | 26.78 ± 1.55 (25.95–27.61) | 26.03 ± 1.36 (25.31–26.75) | 0.002 | 26.25 ± 1.37 (25.52–26.98) | 25.66 ± 1.20 (25.02–26.30) | 0.003 | 26.55 ± 1.96 (25.51–27.59) | 26.67 ± 1.72 (25.75–27.59) | 0.384 |
| Percent body fat | 25.94 ± 5.35 (23.09–28.79) | 24.75 ± 5.20 (21.98–27.52) | 0.001 | 25.94 ± 4.99 (23.28–28.60) | 24.88 ± 4.99 (22.22–27.54) | 0.002 | 25.88 ± 5.40 (23.00–28.76) | 25.00 ± 5.52 (22.20–27.82) | 0.014 |
| HR (bpm) | 76.94 ± 2.64 (75.53–78.35) | 75.12 ± 3.63 (73.19–77.05) | 0.031 | 74.62 ± 4.56 (72.19–77.05) | 74.87 ± 4.50 (72.47–77.27) | 0.752 | 76.19 ± 5.13 (73.46–78.92) | 75.81 ± 4.10 (73.63–77.99) | 0.549 |
| SBP (mmHg) | 129.12 ± 8.10 (124.80–133.44) | 129.62 ± 6.74 (126.03–133.21) | 0.843 | 131.00 ± 6.93 (127.31–134.69) | 128.25 ± 6.40 (124.84–131.66) | 0.221 | 125.62 ± 6.90 (121.94–129.30) | 131.62 ± 9.33 (126.65–136.59) | 0.031 |
| DBP (mmHg) | 81.75 ± 3.00 (80.15–83.35) | 81.62 ± 3.28 (79.87–83.37) | 0.926 | 81.62 ± 9.24 (76.70–86.54) | 83.00 ± 3.58 (81.09–84.91) | 0.239 | 82.62 ± 2.39 (82.35–84.89) | 83.50 ± 4.23 (81.25–85.75) | 0.379 |
Abbreviations: CI, confidence interval; HD, high dose green coffee extract; LD, low dose green coffee extract; PL, placebo; BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; M, mean; SD, standard deviation.